Skip to content

Trial Summary

NINJA: Phase II Novel integration of New prostate radiation therapy schedules with adjuvant Androgen deprivation

Acronym:

NINJA

ACTRN/NCT /ethics:

ACTRN12618001806257

Scientific title:

Novel Integration of new prostate radiation therapy schedules with adjuvant androgen deprivation

Sponsor / Cooperative group:

Trans Tasman Radiation Oncology Group

Trial & Patient Characteristics

Cancer TypeProstate
Trial TypeTreatment
PhasePhase II
Age Range18 years and older
SexMale
Tumour Stream -
Cancer StageEarly\In Situ
Anticipated Start Date2018-11-02
Anticipated End Date-

Participating Hospitals

HospitalRoyal Adelaide Hospital
Clinical Trial CoordinatorAnne Milton
Emailanne.milton@sa.gov.au
Phone08 7074 2342
Principal InvestigatorDr Peter Gorayski
Recruitment StatusRecruiting